DFX Intelligence

Data Factory

Borealis Biosciences

Our team has extensive expertise in kidney disease, targeted delivery of RNA therapeutics, translational systems biology and data sciences, translational biology, chemistry, DMPK and pharmacology.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:2af9aab9-d3bf-42d8-a5b2-75fe313b52fc

Data as of Sep 17, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 19, 2026, 1:29 PM UTC and rebuilt at most every 15 minutes.

Relationships: 1
Dated events: 0
On other graphs: 0
Observed: Sep 13, 2026 to Sep 17, 2026
5 observations

Across DFX

This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Rounds: 0
Investors: 1
People: 0
Website: borealisbio.com

Investors

Investor	Class	Fund	Partner	Role	Attribution
Westlake Biopartners, LLC	Multi stage VC	n/a	n/a	unknown	Unknown

Relationships

Invested in (1)

← Westlake Biopartners, LLCFirmPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site

Dated events

No dated event names this entity yet.

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:2af9aab9-d3bf-42d8-a5b2-75fe313b52fc
First observed: Sep 13, 2026
Last observed: Sep 17, 2026 2 days ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.